Miltenyi Biotec-tested panel 39 (MBTP 39)
This application protocol describes the analysis of plasma cells from human multiple myeloma bone marrow by flow cytometry.
|Specificity||Clone||Purpose||Fluorochrome||Detection filter (nm) (laser)|
|CD138||44F9||Plasma cells (PCs)||APC||655–730 (red)|
|CD38||REA671||PCs||Vio® Bright FITC||525/50 (blue)|
|CD235a||REA175||RBC||PE-Vio 770||750LP (blue)|
|CD45||REA747||Erythroblast exclusion||VioGreen™||525/50 (violet)|
|CD19||REA675||Myeloma PCs||VioBlue®||450/50 (violet)|
|CD28||REA612||PCs||APC-Vio 770||750 LP (red)|
|CD56||REA196||Myeloma PCs||APC-Vio 770||750 LP (red)|
|Propidium iodide||-||Viability||-||655–730 (blue)|
Unless otherwise specifically indicated, Miltenyi Biotec products and services are for research use only and not for therapeutic or diagnostic use.
If not otherwise specified, all marks displayed on the Miltenyi Biotec Internet site and documents are subject to the trademark rights of Miltenyi Biotec, including each of Miltenyi Biotec's primary brands, its model name plates, and its corporate logos and emblems.
For copyright note and a complete list of trademarks visit www.miltenyibiotec.com/legalnotes.
Seems like you are coming from USA!
Do you want to visit our website in your country?